ICE-HBV
  • Twitter
  • Contact Us
  • Login
  • About
    • About ICE-HBV
    • Governing Board
    • Sponsors & Partners
    • Hep B Cure
  • Events
    • Events
  • Tools
    • Protocols
    • Submit protocol
    • HBV Cure FAQs
    • Viral Hepatitis Commodities Access in RLS
  • Symposia
    • 2022 HBV Cure: Promises and challenges of Immunotherapies
    • 2021 HBV Cure: The Mechanisms Behind Combination Therapies
    • 2020 HBV Serum Biomarkers Workshop
    • 2019 In-Vivo Models Project Group
  • Activities
    • Research Projects & Promotion
    • Scientific Working Groups
    • Stakeholder's Consulting Group
  • Publications
    • Latest News
    • Publications
  • Donate

Author: admin

Abstract submission for ANRS HBV Cure workshop is open until April 21, 2017

POSTED ON: 15 Mar, 2017

 

Apply here.

Please note that the presentations are available as ‘posters’ only.

Deadlines:

Deadline for abstract submission: April 21st, 2017
Notification of acceptance:April 28th, 2017

 

 

Categories ANRS, Workshop

HBV Research Protocols

  • A modified kit-based HBV protein-free DNA extraction from liver tissues and cell cultures for HBV cccDNA Southern blot and qPCR

    • cccDNA quantification from total DNA preparation by qPCR with cccDNA-selective primers is challenging because of the coexisting HBV DNA forms (replicative intermediates, protein-free ... [Read more]
    21 September, 2022
  • A sensitive and rapid Southern blot assay based on branched DNA technology for the detection of HBV DNA in cell culture and liver tissue samples

    • Sothern blot is considered the “gold standard” for cccDNA detection because it can separate the cccDNA from protein-free relaxed circular DNA (pf-rcDNA, aka deproteinated rcDNA (DP-rc... [Read more]
    21 September, 2022
  • An Optimized Ex Vivo Flurospot assay to identify multi-functional HBV-specific T cells in Chronic Hepatitis B patients

    During a traditional FluroSpot assay, low HBV Specific T cell frequencies have hindered effective ex vivo analysis. We overcame this obstacle to measure ex vivo T cell responses in CHB patients, ... [Read more]
    07 March, 2022
  • Fluorescent-bait labelling for the ex vivo detection of HBV antigen-specific B cells

    Fluorescently conjugated antigen-bait systems have been extensively used to identify antigen-specific B cells and probe humoral immunity across different settings. Using this principle, HBV antig... [Read more]
    30 April, 2021
  • Tetramer enrichment for HBV-specific CD8+ T cells

    The frequency of HBV-specific CD8+ T cells can be very low, depending on the specificity. Therefore, they cannot always be detected by conventional ex vivo tetramer staining using 10[Read more]
    03 July, 2020
  • A fluorescent in situ hybridization (FISH) assay for detection of HBV DNA in cell culture models

    • Although a plethora of knowledge on the molecular life cycle of Hepatitis B Virus has been gained by utilizing classical methods, they can only inform on the average level of the test... [Read more]
    19 June, 2020
  • HBV Ribonuclease H assay resolved by denaturing PAGE

    • This assay characterizes the products of HBV RNase H activity on a DNA:RNA heteroduplex.
    • Products are resolved by denaturing PAGE to assess specificity of cleavage and eff... [Read more]
    06 June, 2019
  • HBV Ribonuclease H FRET Assay

    • This assay detects the activity of HBV RNaseH using fluorescence resonance energy transfer
    • The ribonuclease H (RNaseH) substrate is an RNA DNA heteroduplex in which an RNA... [Read more]
    06 June, 2019
  • A Southern Blot Assay for Detection of HBV cccDNA from Cell Cultures

    • As an essential component of HBV life cycle, the viral covalently closed circular DNA (cccDNA) is synthesized and maintained at low copy numbers in the nucleus of infected hepatocytes... [Read more]
    03 June, 2019
  • Modeling HBV infection and therapy in immunodeficient NOD-Rag1-/-IL2RgammaC-null (NRG) fumarylacetoacetate hydrolase (FAH) knockout mice with human chimeric liver

    • Besides human, only a few species have been reported to be permissive for Hepatitis B virus (HBV) infection(1-3). Human liver chimeric mouse models have been developed to overcome the... [Read more]
    25 May, 2019

ICE-HBV Twitter Follow

ICE_HBV
ice_hbv ICE-HBV @ice_hbv ·
2 Feb

‼️ Have you seen our #HBVCureFAQs web series yet?! Check out the videos from world #HBV experts explaining the #HBVCure research!
👉🔗https://ice-hbv.org/hbv-cure-faqs/

Reply on Twitter 1621199922497290242 Retweet on Twitter 1621199922497290242 4 Like on Twitter 1621199922497290242 8 Twitter 1621199922497290242
Retweet on Twitter ICE-HBV Retweeted
testoniresearch Barbara Testoni @testoniresearch ·
1 Feb

Great joint effort! @agenceANRS @ipcureb https://twitter.com/ice_hbv/status/1620753575982010369

ICE-HBV @ICE_HBV

‼️👉 Keep an eye out for Dr Maura Dandri and team at @UKEHamburg @DZIF_ new publication coming out in @Gut_BMJ titled "Quantification of the Hepatitis B Virus cccDNA: Evidence-based guidelines for
monitoring the key obstacle of HBV cure"
Congrats to all authors!

Reply on Twitter 1620802970110795780 Retweet on Twitter 1620802970110795780 1 Like on Twitter 1620802970110795780 3 Twitter 1620802970110795780
Load More...
  • Login
  • Subscribe to updates
  • Download our Brochure
  • Login
  • Subscribe for news
  • Download our brochure
  • Login
  • Subscribe to updates
  • Download our Brochure
Copyright © 2023 ICE-HBV. All rights reserved.